According to the health department’s recent report, among the 2,394 HIV-positive individuals in Mau, 1,147 are men, 1,151 are women, and 85 are children.
A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...
Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...
Early diagnosis and prompt antiretroviral therapy initiation are critical for children due to the rapid progression of HIV in ...
The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...
Ibalizumab continues to demonstrate long-term efficacy and safety as part of combination antiretroviral therapy in heavily ...
IN the quiet corners of Tanzania’s bustling cities and rural villages, a silent crisis is unfolding. Kidney disease, often ...
On the outskirts of the city, meanwhile, millions of life-saving doses sit on the shelves of a warehouse, unused and ...
Funding cuts have disrupted HIV prevention, treatment, and care programmes, putting PLHIV at higher risk of infections and ...
South African researchers are making significant strides in validating traditional medicines for HIV treatment, highlighting ...